| 1 |
Hosseini S, Mohammadnejad J, Salamat S, Beiram Zadeh Z, Tanhaei M, Ramakrishna S. Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review. Materials Today Chemistry 2023;29:101400. [DOI: 10.1016/j.mtchem.2023.101400] [Reference Citation Analysis]
|
| 2 |
Ünak P, Yasakçı V, Tutun E, Karatay KB, Walczak R, Wawrowicz K, Żelechowska-matysiak K, Majkowska-pilip A, Bilewicz A. Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with 44Sc and 47Sc for Theranostic Application. Pharmaceutics 2023;15:850. [DOI: 10.3390/pharmaceutics15030850] [Reference Citation Analysis]
|
| 3 |
S V, Kajal K, Mondal S, Wahan SK, Das Kurmi B, Das Gupta G, Patel P. Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016-2021). Chem Biodivers 2023;20:e202200847. [PMID: 36721068 DOI: 10.1002/cbdv.202200847] [Reference Citation Analysis]
|
| 4 |
Zhang P, Cui Y, Wang J, Cheng J, Zhu L, Liu C, Yue S, Pang R, Guan J, Xie B, Zhang N, Qin M, Jing L, Hou Y, Lan Y. Dual-stimuli responsive smart nanoprobe for precise diagnosis and synergistic multi-modalities therapy of superficial squamous cell carcinoma. J Nanobiotechnology 2023;21:4. [PMID: 36597067 DOI: 10.1186/s12951-022-01759-1] [Reference Citation Analysis]
|
| 5 |
Tang J, Ouyang Q, Li Y, Zhang P, Jin W, Qu S, Yang F, He Z, Qin M. Nanomaterials for Delivering Antibiotics in the Therapy of Pneumonia. Int J Mol Sci 2022;23. [PMID: 36555379 DOI: 10.3390/ijms232415738] [Reference Citation Analysis]
|
| 6 |
Li D, Zhuang P, Mei X. Flexible regulation of reactive oxygen species by sustainable cluster drugs. Materials Today Chemistry 2022;26:101093. [DOI: 10.1016/j.mtchem.2022.101093] [Reference Citation Analysis]
|
| 7 |
Karim ME, Haque ST, Al-busaidi H, Bakhtiar A, Tha KK, Holl MMB, Chowdhury EH. Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01418-x] [Reference Citation Analysis]
|
| 8 |
Harini K, Girigoswami K, Anand AV, Pallavi P, Gowtham P, Elboughdiri N, Girigoswami A. Nano-mediated Strategies for Metal Ion–Induced Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases. Curr Pharmacol Rep 2022. [DOI: 10.1007/s40495-022-00307-7] [Reference Citation Analysis]
|
| 9 |
Sikder A, Vambhurkar G, Amulya E, Bagasariya D, Famta P, Shah S, Khatri DK, Singh SB, Sinha VR, Srivastava S. Advancements in redox-sensitive micelles as nanotheranostics: A new horizon in cancer management. J Control Release 2022;349:1009-30. [PMID: 35961470 DOI: 10.1016/j.jconrel.2022.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Zhong Y, Zeng X, Zeng Y, Yang L, Peng J, Zhao L, Chang Y. Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases. Nano Today 2022;45:101554. [DOI: 10.1016/j.nantod.2022.101554] [Reference Citation Analysis]
|
| 11 |
Niu Y, Yang Y, Yang Z, Wang X, Zhang P, Lv L, Liu Y, Liu Y, Zhou Y. Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment. Nano Today 2022;45:101529. [DOI: 10.1016/j.nantod.2022.101529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Liang S, Liao G, Zhu W, Zhang L. Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies. Biomater Res 2022;26. [DOI: 10.1186/s40824-022-00275-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Lin X, Li F, Gu Q, Wang X, Zheng Y, Li J, Guan J, Yao C, Liu X. Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy. Acta Biomater 2022;146:406-20. [PMID: 35470078 DOI: 10.1016/j.actbio.2022.04.029] [Reference Citation Analysis]
|
| 14 |
Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 2022. [PMID: 35729778 DOI: 10.1021/acsnano.2c00128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Zheng Z, Duan A, Dai R, Li Y, Chen X, Qin Y, Ren S, Li R, Cheng Z, Zhang R. A "Dual-Source, Dual-Activation" Strategy for an NIR-II Window Theranostic Nanosystem Enabling Optimal Photothermal-Ion Combination Therapy. Small 2022;:e2201179. [PMID: 35665998 DOI: 10.1002/smll.202201179] [Reference Citation Analysis]
|
| 16 |
Li D, Wang T, Li L, Zhang L, Wang C, Dong X. Designed formation of Prussian Blue/CuS Janus nanostructure with enhanced NIR-I and NIR-II dual window response for tumor thermotherapy. Journal of Colloid and Interface Science 2022;613:671-80. [DOI: 10.1016/j.jcis.2022.01.074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Li Y, Zhang P, Tang W, McHugh KJ, Kershaw SV, Jiao M, Huang X, Kalytchuk S, Perkinson CF, Yue S, Qiao Y, Zhu L, Jing L, Gao M, Han B. Bright, Magnetic NIR-II Quantum Dot Probe for Sensitive Dual-Modality Imaging and Intensive Combination Therapy of Cancer. ACS Nano 2022. [PMID: 35442624 DOI: 10.1021/acsnano.2c01153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 18 |
Yue S, Zhang X, Xu Y, Zhu L, Cheng J, Qiao Y, Dai S, Zhu J, Jiang N, Wu H, Zhang P, Hou Y. The influence of surface charge on the tumor-targeting behavior of Fe3O4 nanoparticles for MRI. J Mater Chem B 2022. [PMID: 34994759 DOI: 10.1039/d1tb02349g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Zhang P, Jing L. Nanoprobes for Visualization of Cancer Pathology in Vivo※. Acta Chimica Sinica 2022;80:805. [DOI: 10.6023/a21120609] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
